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INTRODUCTION 
Retinopathy of Prematurity (ROP) is one of the leading causes of 
childhood blindness. As a result of the improved and careful management 
in the neonatal intensive care units the survival rate of very small 
premature infants dramatically increased during the last two decades. A 
new ROP epidemic started among the very low birth weight and high-risk 
preterm infants. The etiology ROP is multifactorial (more than 50 
recognized risk factors have been reported) and the pathomechanism is 
still not clear. Better understanding of the environmental and individual 
factors that cause retinal neovascularisation and lead to this disabling 
condition requires further investigation. One of the proposed 
pathomechanisms of ROP is oxygen radical injury. It occurs when the 
production of free radicals overwhelms body's natural antioxidant 
capacity, resulting in oxidative damage of the susceptible tissues. 
AIM OF THE STUDY 
On the hypothesis that a special susceptibility of premature infants with 
ROP does exist (e.g. some kind of trace element or vitamin deficiency 
causing decreased activity of antioxidant enzymes), retrospective and 
prospective studies (including maternal biochemical examinations as 
well) were carried out. The similarity between the erythrocyte (RBC) 
membrane and the immature retina in their structure (very long chain 
unsaturated fatty acids with a marked susceptibility to oxidative insult), 
their metabolism (high demands for glucose and oxygen) and their 
antioxidant defense mechanisms (glutathione-dependent defense systems, 
glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) etc.) led 
us to study RBC as indicator of the oxidative status of our patients. 
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STUDY DESIGN AND PATIENTS 
Retrospective study 
Supposing that premature infants may have defects in their antioxidant 
systems which can be detected later, even in childhood, a retrospective 
study of 50 ROP patients of different ages (between 6 weeks and 6 years), 
who had been bom prematurely (gestational age: 28.7±1.3 weeks; birth 
weight: 1210±313 g; mean±SD) and were suffering from different stages 
of ROP (stage 2-5) was carried out. Biochemical examinations were 
carried out on 12 preterm infants at the time of their first ROP screening 
at the Perinatal Intensive Care Unit, as well as on 14 infants and 24 
children suffering from a visual handicap due to preceding ROP at the 
ophthalmological follow-up clinic. 
Prospective study 
After confirming the presence of the diminished antioxidant defense 
capacity in our retrospective study, a prospective study was planned. Our 
one-year study was carried out on 60 premature infants (gestational age: 
32.8±3.1 weeks, range: 26-35 weeks); birth weights under 2000 g (mean: 
1529±302 gs, range: 980-1840) admitted immediately after birth to the 
Perinatal Intensive Care Unit of the Department of Pediatrics for oxygen 
therapy (FIO2 >0.6 longer than 24 hrs). In our prospective study a close 
ophthalmological follow-up was provided in order to monitor the 
presence and the outcome of ROP. The first ophthalmological 
examination (ROP screening) was carried out at 34-36 weeks of 
postconceptional age (postnatal 6.2±1.2 weeks). The ocular investigation 
was repeated every 1 or 2 weeks thereafter until our patients' first 
birthday. Direct and indirect ophthalmoscopy was performed, following 
maximal pupillary dilatation in order to monitor the retinal 
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vascularisation. In some cases, ultrasound was used as well to evaluate the 
severity of retinal manifestation. ROP staging was based on the 
International Classification of ROP. According to their ophthalmological 
status, patients were divided into 3 groups: 1) ROP free group (n=27; 
gestational age 33.7± 2.5 weeks; birth weight: 1707±306 g; mean±SD): 
the fundus was normal. 2) ROP suspect group (n=28, gestational age: 
32.3±3.2 weeks; birth weight: 1418±273 g): because of the abnormal 
tortuosity of retinal vessels and the pale, avascular temporal retinal 
periphery, this group required special attention, they were given vitamin E 
(30 mg oral doses twice a week). 3) Pretreshold ROP group (n=5; 
gestational age: 29.8±3.2 weeks; birth weight: 1310±330 g; p<0.05): stage 
1-2 and 2-3 ROP, different types of junctions were seen between the 
vascular and avascular part of the retina from a demarcation line to a 
highly elevated ridge. None of our patients suffered from severe, stage 4-5 
ROP. 
Maternal examinations 
We examined the biochemical parameters of available mothers as well, 
supposing the mother's responsibility in determining the infant's 
antioxidant defense capacity, via her nutritional status (e.g. vitamin and 
trace element supply) and lifestyle (e.g. smoking) during pregnancy. The 
biochemical examination was carried out on 44 mothers at the time of the 
first ROP-screening. 
METHODS 
The ratio of oxidized/reduced glutathione (GSSG/GSH) was used as a 
parameter of in vivo oxidative stress. Highly sensitive and specific 
separate determinations of GSSG and GSH+GSSG concentrations were 
carried out using the enzymatic recycling method described by Tietze. The 
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degree of GSH stability after an in vitro oxidative insult (a method 
evolved by Beutler) and the presence and amount of hemoglobin (Hb) 
oxidation products (methemoglobin, hemichrome) reflected the 
antioxidant protective capacity of RBCs. Selenium (Se) concentrations in 
erythrocytes were determined by the diaminonaphthalene fluorometric 
method according to Lalonde. Plasma concentrations of free sulphydryl 
groups (-SH) were determined by a spectrophotometric method described 
by Koster. Plasma concentrations of vitamin E (alpha-tocopherol) and 
vitamin A (retinol) were measured simultaneously by the HPLC method 
according to Catignani. Plasma ferritin concentration, as an indicator of 
the body's iron pool, was measured by a radioimmunassay method. 
RESULTS AND DISCUSSION 
Retrospective study 
GSH redox system 
A significant increase in the GSSG/GSH as a specific sign of acute, in 
vivo oxidative stress was only seen in the patients younger than 3 months 
old with simultaneous active ROP. There was a significant negative 
correlation between the GSH oxidation (measured either as GSSG 
concentration or as the ratio GSSG/GSH) and the total Hb concentration 
in the ROP patients less than 3 months old. Thus, the extent of in vivo 
oxidative stress showed a correlation with the extent of anemia (due to 
oxidative hemolysis) in these prematures with simultaneous active ROP. 
In vitro oxidative insult and response: GSH stability test and hemoglobin 
oxidation 
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Following an in vitro oxidative stress compromised antioxidant defense 
capacity could be detected in all ROP patients. Greater fall in GSH was 
seen in all the ROP patient groups as compared with the controls. The 
proportions of oxidized derivatives of Hb (metHb+hemichrome) were 
higher in each ROP group as well. Thus, greater GSH depletion was 
accompanied by a more extensive oxidation of Hb after a calibrated in 
vitro oxidative stress, reflecting defective GSH recycling not only in 
active ROP patients but also in infants and children with preceding ROP. 
Blood selenium concentration 
Very low blood Se levels were measured in all ROP patient groups. 
Linear relationship has been reported between the RBC's GSH-Px activity 
and Se concentrations in several studies. Thus, the very low blood Se 
levels measured by us reflected reduced GSH-Px activity in each age 
group. Surprisingly, Se status of our healthy controls was low as well in 
comparison to the Western-European normal Se values, reflecting a 
general Se deficiency of the Hungarian population. 
Prospective study 
Individual parameters: gestational age and birth weight 
The gestational age and the birth weight of patients diagnosed with stage 
1-3 ROP were significantly lower, which stresses the importance of 
immaturity in the pathogenesis of ROP. 
GSH redox system 
A significant increase in the GSSG/GSH ratio as a specific sign of acute 
oxidative stress could be seen in all of our premature patient groups. We 
did not find significant differences either in concentrations and ratios or in 
stability of GSH between the patient groups according to their ROP status. 
7 
Concentrations of free sulfhydryl groups in the prematures and their 
mothers 
Concentration of plasma -SH groups, which is a reliable indicator of the 
actual antioxidant status of the body, was significantly lower in both of 
our ROP patients and in their mothers. 
Selenium concentrations in the prematures and their mothers 
Extremely low RBC Se levels were detected both in the ROP patients and 
in their mothers. The maternal Se deficiency observed by us may lead to 
diminished retinal GSH-Px activity in the fetal retina. GSH-Px, the 
enzyme which provides the only antioxidant protection of human retinal 
precursor ('spindle') cells before the 28th gestational week, is already 
detectable in retinas of human embryos weighing more than 160g. For the 
proper GSH-Px synthesis and enzymatic activity Se is required, which 
depends on the maternal supply. The placenta has some barrier function 
towards Se (3:2) but depending on the maternal level Se does get into the 
fetal circulation and has positive influence on the fetal antioxidant 
defense. 
The effect of vitamin E administration on the concentrations of free 
sulfhydryl groups and RBC selenium levels 
In the ROP-suspect group of prematures oral vitamin E treatment was 
started, which was closely monitored by repeated plasma vitamin E level 
determinations. At the age of 6 months we could already see the positive 
effect of vitamin E on the ophthalmological status, i.e. the avascular, pale 
periphery began to be vascularised and slow regression was seen. At this 
time a biochemical investigation was carried out. Both the concentrations 
of free sulfhydryl groups and Se were increased after per os vitamin E 
treatment. The well-known synergism between vitamin E and Se provides 
the explanation to this result. 
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Plasma concentrations of antioxidant vitamins: E and A 
There was a marked decrease in plasma vitamin E concentrations in the 
patient group diagnosed with ROP. However, plasma vitamin E levels in 
the ROP free premature groups were also slightly below the lowest level 
of the physiological range, reflecting a general vitamin E deficiency of the 
preterm neonate. Maternal vitamin E concentrations showed a very 
similar tendency: the lowest vitamin E levels were detected in those 
mothers whose preterm babies suffered from active ROP. On the other 
hand, plasma vitamin A concentrations were only lower in those 
premature infants suffering from ROP. 
Plasma ferritin levels 
Plasma ferritin concentration, which is an indicator of the body's iron 
pool, was significantly higher in our ROP patients. Surprisingly, maternal 
ferritin levels showed the opposite tendency: the lowest plasma ferritin 
levels were detected in the mothers of the ROP patients, but ferritin levels 
in the other two mother groups were still lower than that of their babies. 
Thus, in spite of the mothers' obvious iron deficiency, fully saturated iron 
pool fully saturated iron pools were detectable in the preterm infants. 
CONCLUSIONS 
The aim of our work was to investigate the role of oxidative stress in the 
pathogenesis of ROP. In order to detect the presence of oxidative stress 
and find biochemical markers in ROP patients, which explain their special 
susceptibility to oxidative injury, retrospective and prospective studies 
were carried out. Our results led us to the following conclusions. 
1. The RBC's GSSG/GSH ratio is an adequate parameter to indicate the 
in vivo oxidative stress in the acute phase of ROP. The signs of an 
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acute oxidative stress could only be seen in the 3-months-old or 
younger patients, supporting Saugstad's hypothesis that ROP is a part 
(as the retinal manifestation) of the 'Oxygen Radical Disease of 
Prematurity'. 
2. In response an in vitro oxidative stress compromised antioxidant 
defense capacity could be detected in all ROP patients even later in 
childhood suggesting that ROP probably develops in those premature 
infants who have reduced antioxidant defense capacity (either genetic 
or acquired). 
3. Selenium is not only an integral part of GSH-Px enzyme, but also acts 
as an antioxidant itself by playing a role in the regeneration of vitamin 
E. The very low selenium levels measured in all our ROP patients both 
in our retrospective and prospective studies suggest that selenium 
depletion in Hungary might play an important role in the pathogenesis 
of ROP. 
4. The fact that during our screening for ROP in our prospective study 
we could only diagnose 5 cases of mild ROP among 60 high-risk 
premature infants, leads us to the conclusion that the management of 
preterm infants at the Perinatal Intensive Care Unit of our University 
and the secondary treatment at Children's Hospital is very careful. 
5. We found that gestational ages and the birth weights of patients 
diagnosed with ROP were significantly lower, which confirms the 
importance of immaturity as one of the most significant risk factors for 
ROP. 
6. The close correlation found between the low serum levels of -SH and 
Se of mothers and babies suggest that dietary supplementation with 
sulfur containing aminoacids (e.g.methionin, cystein) and Se during 
pregnancy would improve the antioxidant capacity of premature 
infants. 
7. Considering the fact that marked decrease of plasma vitamin E 
concentrations were determined both in our ROP patients and in their 
mothers, we can conclude that an 'antioxidant cocktail' suggested in 
literature (containing Se and vitamin E) given to the high-risk mothers 
(advanced age, smoking, toxemia, pregnancy-induced hypertension, 
etc.) before delivery might be useful in prevention of ROP. 
8. According to our results, per os vitamin E supplementation seems to 
have a positive effect on preventing the progression of ROP. Because 
of the potential harmful side effects, however, vitamin E 
administration must be closely monitored by repeated measurements 
of plasma vitamin E levels. 
9. The fact, that in spite of iron deficiency in their mothers, fully 
saturated iron pools were detectable in the preterm infants, leads us to 
the conclusion that during the first 6 weeks of life iron overload might 
be one of the main factors leading to ROP. Therefore we suggest that 
in the clinical management of premature infants all interventions that 
may result in excessive iron load (transfusions, iron supplementation, 
etc.) may contribute to the development of ROP. We propose that the 
administration of erythropoeitin (EPO) as a treatment option for 
chronic anemia might be useful in the prevention of ROP by reducing 
the need for transfusions. 
11 
MESSAGE 
Although the proportion of premature infants who become blind of ROP 
has decreased, the number of children with visual disability is still high. 
As a pediatric ophthalmologist I have seen retinas getting detached 
despite the appropriate treatment resulting blindness and phthisis 
(disfiguring shrinkage) of the affected eye. Even effective and appropriate 
ophthalmological interventions have side effects: decreased peripheral 
vision from cryotherapy, transient or permanent cataracts from 
vitreoretinal surgery, etc. Fortunately, ROP has a tendency for 
spontaneous regression, but even in these cases infants are predisposed to 
amblyopia, strabismus and other disorders requiring long-lasting 
ophthalmological treatment. For this reason, the only solution for 
retinopathy of prematurity would be prevention. In order to be able to 
prevent this disabling neovascular retinopathy we have to be determined 
in the continuing search for possibly preventable environmental and 
individual factors leading to ROP. According the Lancet Editorial: 'The 
focus of preventive attention should probably shift away from 
neonatology towards obstetrics and public health, since it is only by 
developing effective methods of avoiding premature delivery and extreme 
low birthweight that we are likely to bring the unexpectedly longrunning 
saga of ROP to a close '. 
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